The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1212-1220

  Ray, Sutapa ^a,b   Ju, Xiaoxi ^a   Sun, Hong ^a   Finnerty, Celeste C ^a   Herndon, David N ^b   Brasier, Allan R ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 PROCOLLAGEN; CYCLIN D1; FIBRONECTIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; MYC PROTEIN; PROCOLLAGEN; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT3 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84876680937     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.499     Document Type: Article

References (47)

1. Abergel RP, Pizzurro D, Meeker CA et al. (1985) Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 84:384-90
2. Bombaro KM, Engrav LH, Carrougher GJ et al. (2003) What is the prevalence of hypertrophic scarring following burns? Burns 29: 299-302
3. Bowman T, Broome MA, Sinibaldi D et al. (2001) Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogen-esis. Proc Natl Acad Sci USA 98:7319-24
4. Castagnoli C, Trombotto C, Ondei S et al. (1997) Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 23:565-72
5. Dauer DJ, Ferraro B, Song LX et al. (2005) Stat3 regulates genes common to both wound healing and cancer. Oncogene 24:3397-408
6. Deitch EA, Wheelahan TM, Rose MP et al. (1983) Hypertrophic burn scars: analysis of variables. J Trauma 23:895-8
7. Ebihara N, Matsuda A, Nakamura S et al. (2011) Role of the IL-6 classic-and trans-signaling pathways in corneal sterile inflammation and wound healing. Invest Ophthalmol Vis Sci 52:8549-57
8. Eckner R, Ewen ME, Newsome D et al. (1994) Molecular cloning and functional ananlysis of the adenovirus E1A-associated 300kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8:869-84
9. Feghali CA, Bost KL, Boulware DW et al. (1994) Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmu-nity 17:309-18
10. Finnerty CC, Herndon DN, Przkora R et al. (2006) Cytokine expression profile over time in severely burned pediatric patients. Shock 26:13-9
11. Finnerty CC, Jeschke MG, Herndon DN et al. (2008) Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med 14:553-60
12. Ghazizadeh M, Tosa M, Shimizu H et al. (2007) Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 127: 98-105
13. Haga S, Terui K, Zhang HQ et al. (2003) Stat3 protects against Fas-induced liver injury by redox-dependent and-independent mechanisms. J Clin Invest 112:989-98
14. Hou T, Ray S, Brasier AR (2007) The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 282:37091-102
15. Hou T, Ray S, Lee C et al. (2008a) The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. J Biol Chem 283:30725-34
16. Hou T, Tieu BC, Ray S et al. (2008b) Roles of IL-6-gp130 Signaling in Vascular Inflammation. Curr Cardiol Rev 4:179-92
17. Igarashi A, Nashiro K, Kikuchi K et al. (1996) Connective tissue growth factor gene expression in tissue sections from localized scler-oderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-33
18. Jeschke MG, Chinkes DL, Finnerty CC et al. (2008) Pathophysiologic response to severe burn injury. Ann Surg 248:387-401
19. Jones SA, Horiuchi S, Topley N et al. (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43-58
20. Jones SA, Richards PJ, Scheller J et al. (2005) IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25:241-53
21. Kushner I (1988) The acute phase response: an overview. Methods Enzymol 163:373-83
22. Lim CP, Phan TT, Lim IJ et al. (2006) Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. Oncogene 25:5416-25
23. Lim CP, Phan TT, Lim IJ et al. (2009) Cytokine profiling and Stat3 phosphor-ylation in epithelial-mesenchymal interactions between keloid keratino-cytes and fibroblasts. J Invest Dermatol 129:851-61
24. Matsui T, Ito C, Oda M et al. (2011) Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars. J Pharm Pharmacol 63:960-6
25. Nowak DE, Tian B, Brasier AR (2005) Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipi-tation. Biotechniques 39:715-25
26. O'Brien CA, Manolagas SC (1997) Isolation and characterization of the human gp130 promoter. Regulation by STATS. J Biol Chem 272:15003-10
27. Penn JW, Grobbelaar AO, Rolfe KJ (2012) The role of the TGF-b family in wound healing, burns and scarring: a review. Int J Burns Trauma 2:18-28
28. Ray S, Boldogh I, Brasier AR (2005) STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology 129:1616-32
29. Ray S, Lee C, Hou T et al. (2010) Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol Endocrinol 24:391-401
30. Ray S, Lee C, Hou T et al. (2008) Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids Res 36:4510-20
31. Sano S, Chan KS, Digiovanni J (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1-14
32. Scheller J, Rose-John S (2006) Updating interleukin-6 classic-and trans-signaling. Signal Transduct 6:240-59
33. Scott PG, Ghahary A, Tredget EE (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16:271-87
34. Shahar I, Fireman E, Topilsky M et al. (1996) Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol 79:244-51
35. Sheridan RL, Tompkins RG (2004) What's new in burns and metabolism. J Am Coll Surg 198:243-63
36. Sidgwick GP, Bayat A (2012) Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 26:141-52
37. Sinibaldi D, Wharton W, Turkson J et al. (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419-27
38. Sporri B, Muller KM, Wiesmann U et al. (1999) Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int Immunol 11:1053-8
39. Tan PL, Farmiloe S, Yeoman S et al. (1990) Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol 17:1608-12
40. Tao L, Liu J, Li Z et al. (2010) Role of the JAK-STAT pathway in proliferation and differentiation of human hypertrophic scar fibroblasts induced by connective tissue growth factor. Mol Med Report 3:941-5
41. Tieu BC, Lee C, Sun H et al. (2009) An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 119:3637-51
42. Timofeeva OA, Gaponenko V, Lockett SJ et al. (2007) Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target. ACS Chem Biol 2:799-809
43. van Zuijlen PP, Vloemans JF, van Trier AJ et al. (2001) Dermal substitution in acute burns and reconstructive surgery: a subjective and objective longterm follow-up. Plast Reconstr Surg 108:1938-46
44. Vermes C, Jacobs JJ, Zhang J et al. (2002) Shedding of the inter-leukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277:16879-87
45. Yamauchi-Takihara K, Kishimoto T (2000) A role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 10:298-303
46. Zhang Z, Finnerty CC, He J et al. (2011) Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children. Burns 38:236-46
47. Zunwen L, Shizhen Z, Dewu L et al. (2012) Effect of tetrandrine on the TGF-b-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro. Burns 38:404-13